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Abstract
 
Mice deficient in interleukin (IL)-2 production or the IL-2 receptor 
 
 
 
 or 
 
 
 
 chains develop a
 
lethal autoimmune syndrome. CD4
 
 
 
 regulatory T cells have been shown to prevent autoimmune
diseases, allograft rejection, and to down-regulate antibody responses against foreign antigens.
To assess the role of IL-2 in the generation and function of regulatory T cells, we transferred
CD4
 
 
 
 T cells from mice genetically deficient in IL-2 or IL-2R
 
 
 
 (CD25) expression. A small
number of splenic or thymic CD4
 
 
 
 T cells from IL-2 knockout mice can protect mice from
spontaneous experimental autoimmune encephalomyelitis (EAE). In contrast, splenic or thy-
mic CD4
 
 
 
 T cells from CD25 knockout donor mice conferred little or no protection. We
conclude that T cells with regulatory potential can develop, undergo thymic selection, and mi-
grate to the peripheral lymphoid organs in the absence of IL-2, and do not protect from disease
by means of IL-2 secretion. However, IL-2 signaling in regulatory T cells is essential for their
protective function. Altogether, our results favor a model whereby IL-2 induces regulatory T
cell activity.
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Introduction
 
IL-2 has been known for many years as a T cell growth-
promoting factor. It was therefore unexpected to find that
mice deficient in IL-2 production or the IL-2 receptor 
 
 
 
and 
 
 
 
 chains develop a lethal lymphoproliferative and au-
toimmune syndrome which has subsequently been referred
to as “IL-2-deficiency syndrome” (1–4). The phenotype of
the IL-2 and IL-2R
 
 
 
 and 
 
 
 
 KO mouse indicates that while
the T cell survival/ growth promoting capacity of IL-2 can
be exerted by other growth/survival factors, IL-2 is essen-
tial for the down-regulation of immune responses.
The role of IL-2 in immune tolerance appears to be
twofold. First, it has been shown that IL-2 is critical in pro-
gramming T cells for activation-induced cell death (AICD;
references 5–7). It is likely that this function of IL-2 is de-
pendent on its ability to increase surface expression of Fas
ligand (FasL) and suppress expression of the inhibitor of
apoptosis FLIP (8). Second, it is becoming increasingly
apparent that besides contributing to AICD, IL-2 plays ad-
ditional roles in immune regulation. For instance, Suzuki et
 
al. showed that the lymphoproliferative syndrome in IL-2R
 
 
 
KO mice could be rescued by a bone marrow transplant
from wild-type mice (9). In this case, there was no IL-2
 
signaling in the T cells of the recipient mice, thus the IL-2R
 
 
 
donor-derived cells were contributing to immune toler-
ance by mechanisms other than IL-2-promoted AICD of
the host cells. Klebb et al. (10) treated IL-2 KO mice with
rhIL-2, and showed that splenocytes and thymocytes from
IL-2–treated IL-2 KO mice could enhance survival of un-
treated IL-2 KO mice. In these experiments, however,
transfer of large numbers of cells (2 
 
 
 
 10
 
7
 
 splenocytes and
5 
 
 
 
 10
 
7
 
 thymocytes) was required and the ensuing protec-
tion was partial. Malek et al. (11) showed that proximal lck
promoter-driven transgenic expression of IL-2R
 
 
 
 chain
was sufficient to prevent the lymphoproliferation associated
with lack of IL-2 signaling in IL-2R
 
 
 
 KO mice, despite
the fact that IL-2 signaling was greatly diminished in the
peripheral T cells of the transgenic mice. Finally, Wolf
et al. (12) showed that a small number (3 
 
 
 
 10
 
5
 
) of
CD4
 
 
 
CD25
 
 
 
 T cells from wild-type mice prevented the
accumulation of antigen-stimulated TCR transgenic IL-2
KO T cells. As CD4
 
 
 
CD25
 
 
 
 T cells produce little or no
IL-2 (12–14), it is unlikely that the CD4
 
 
 
CD25
 
 
 
 cells
were impeding the accumulation of antigen-stimulated T
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cells through IL-2–promoted AICD. These results are con-
sistent with a defect in the generation or function of regu-
latory T cells in the absence of IL-2.
We sought to determine the role of IL-2 using two ex-
perimental systems in which regulatory T cells (T-reg) have
been shown to play a major role. In the first experimental
system, mice that harbor a monoclonal myelin basic protein
(MBP)-specific 
 
  
 
 T cell repertoire spontaneously develop
experimental autoimmune encephalomyelitis (EAE; refer-
ences 15 and 16). Spontaneous EAE can be prevented by a
single administration of purified CD4
 
 
 
 splenocytes or thy-
mocytes obtained from wild-type syngeneic mice (16, 17).
In the second experimental system, a single immunization
of mice that harbor monoclonal T and B cells leads to a hy-
per IgE response (18). This hyper antibody response against
a foreign antigen can be down-modulated by CD4
 
 
 
 T cells
from wild-type syngeneic donor mice (18). In both experi-
mental systems, the role of IL-2 in regulatory T cell gener-
ation or function was studied by transferring CD4
 
 
 
 T cells
from IL-2 KO mice.
We report here that CD4
 
 
 
 T cells from IL-2 KO donor
mice efficiently protect mice from EAE (and hyper IgE re-
sponses), but CD4
 
 
 
 T cells from CD25 KO mice do not.
We conclude that IL-2 signaling is essential for the appro-
priate function of regulatory T cells; however, regulatory T
cells do not suppress EAE through secretion of IL-2. In ad-
dition, as splenic CD4
 
 
 
 T cells from IL-2 KO mice pro-
tected from EAE, we conclude that generation and selec-
tion of T cells with regulatory potential in the thymus does
not require IL-2.
 
Materials and Methods
 
Mice.
 
All mice were housed under specific-pathogen-free
(SPF) conditions in individually ventilated cages (Thoren) at
the Skirball Institute Central Animal Facility, New York Uni-
versity Medical Center. T/
 
 
 
 
 
 
 
 
 
 mice have been described
(16). In brief, T/
 
 
 
 
 
 
 
 
 
 mice are MBP-specific T cell receptor
transgenic mice crossed to TCR 
 
 
 
 KO mice and TCR 
 
 
 
 KO
mice. These H-2
 
u/u
 
 mice have been extensively backcrossed
into C57Bl/10.PL background, and develop EAE spontane-
ously (16).
17/9 DO11.10 RAG
 
 
 
/
 
 
 
 BALB/c mice have been described
(18). In brief, these mice were generated through the cross of 17/9
influenza hemagglutinin (HA)-specific immunoglobulin heavy
and light chain knocked-in mice, DO11.10 TCR transgenic
mice and RAG-1 KO mice. These H-2
 
d/d
 
 mice have been exten-
sively backcrossed into BALB/c background, and display a
monoclonal OVA 323–339–specific T cell repertoire and a
monoclonal HA-specific B cell repertoire (18).
IL-2 KO mice (19) and CD25 KO mice (3) backcrossed to
C57BL/6 background were purchased from The Jackson Labora-
tory and crossed to C57BL/10.PL mice to incorporate H-2
 
u
 
. IL-2
KO mice (19) backcrossed to BALB/c background were pur-
chased from The Jackson Laboratory.
 
Disease Evaluation.
 
EAE was scored as follows: level 1, limp
tail; level 2, weak or partial leg paralysis; level 3, total hind leg pa-
ralysis; level 4, hind leg paralysis and weak or partial front leg pa-
ralysis; level 5, moribund. The weight of the mice was monitored
twice a week for the duration of the experiments. All protocols
 
involving mice were approved by New York University’s Insti-
tutional and Animal Care Use Committee (IACUC).
 
Immunization for Hyper IgE Response and Serum IgE Determina-
tion by ELISA.
 
These procedures were performed as described
(18). Briefly, 17/9 DO11.10 RAG
 
 
 
/
 
 
 
 BALB/c mice were im-
munized with glutaraldehyde-cross-linked OVA-HA antigen.
Mice were injected by intraperitoneal route with 100 
 
 
 
g of cross-
linked OVA-HA adsorbed onto 1 mg of alum. A single immuni-
zation was performed in all experiments. The concentration of
IgE in serum was determined by ELISA. Plates were coated with
anti-IgE monoclonal antibody LO-ME (Caltag), and bound IgE
was detected using biotinylated anti-IgE monoclonal antibody
R35–118 (BD Biosciences). Purified anti-TNP IgE/
 
 
 
 monoclo-
nal antibody IgE-3 (BD Biosciences) was used as IgE standard.
 
Antibodies and FACS
 
®
 
 Analysis.
 
Anti-MBP TCR clonotypic
antibody (3H12) was generated in our laboratory as described
(16). Anti-OVA TCR (anti DO11.10) clonotypic antibody KJ1–
26 was purchased from Caltag Labs. All other antibodies were
purchased from BD Biosciences or Caltag.
Single cell suspensions in staining buffer (PBS containing 2%
fetal calf serum and 0.1% NaN
 
3
 
), were incubated for 45 min at
4
 
 
 
C with the antibody cocktails. Samples were analyzed in a
FACSCalibur™ instrument (Becton Dickinson).
Intracellular staining of IL-2 production was performed ac-
cording to the protocol recommended by BD Biosciences.
Briefly, cells were treated with 10 ng/ml PMA (Sigma-Aldrich)
and 200 ng/ml ionomycin (Sigma-Aldrich) for 2 h followed by
10 
 
 
 
g/ml brefeldin-A addition (Sigma-Aldrich) for 2 additional
hours. Cells were then surface stained with anti-CD4 and anti-
MBP–specific TCR (3H12) for 20 min at 4
 
 
 
C in staining buffer,
treated for 20 min with Cytofix/Cytoperm solution (BD Bio-
sciences), washed, and incubated with Perm/wash buffer (BD
Biosciences) for 10 min. Cells were washed and incubated in
staining buffer for 45 min with anti–IL-2 (BD Biosciences), and
analyzed on a FACSCalibur™ (Becton Dickinson).
 
Cell Purification and Transfer.
 
Cell purifications were per-
formed by magnetic sorting using a Miltenyi Biotec VarioMACS
apparatus. CD4
 
 
 
 single-positive thymocytes were prepared by
magnetic depletion using anti-CD8 and anti-B220–coupled mag-
netic beads (Miltenyi Biotec). CD4
 
 
 
 splenocytes were prepared
by positive sorting with anti-CD4–coupled beads using positive
sorting columns. Cell purity was checked by FACS
 
®
 
 analysis:
CD8 depletion was 
 
 
 
98% effective, whereas CD4 and B220 de-
pletion were both 
 
 
 
99% effective. Positively sorted cells were
 
 
 
95% pure. Cells were resuspended in PBS and injected intrave-
nously at the indicated doses.
 
Online Supplemental Material.
 
The online supplemental data
contains three figures, Figs. S1, S2, and S3. Online supplemental
material is available at http://www.jem.org/cgi/content/full/
jem.20020190/DC1.
 
Results
 
Splenic and Thymic CD4
 
 
 
 Cells from IL-2 KO Mice Prevent
Spontaneous Encephalomyelitis.
 
To determine the role of
IL-2 in the control of spontaneous EAE by regulatory lym-
phocytes, we transferred 3 
 
 
 
 10
 
5
 
 CD4
 
 
 
 T cells from 3–4-
wk-old IL-2 KO mice and IL-2
 
 
 
 littermates into 4-wk-old
T/
 
 
 
 
 
 
 
 
 
 IL-2
 
 
 
 recipient mice. The number of transferred
cells (3 
 
 
 
 10
 
5
 
) is among the smallest number of wild-type
cells that reproducibly confers full protection against spon-
taneous EAE (20). We used a low dose of cells because this 
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would facilitate the detection of a partial loss in regulatory
T cell function. As shown in Fig. 1, A and B, splenic cells
from IL-2 KO mice very effectively prevented spontaneous
EAE. Recipient mice showed no weight loss or any signs
of lymphoproliferative or wasting disease for as long as they
were observed. In contrast, all monoclonal T/
 
 
 
 
 
 
 
 
 
 mice
that did not receive donor-derived cells developed EAE
spontaneously (Fig. 1, A and B).
The reconstitution by donor-derived cells was moni-
tored 20 and 40 d after cell transfer by analysis of peripheral
blood from the recipient mice. Donor and host-derived T
cells can be distinguished with the use of the anti-MBP
TCR clonotypic antibody 3H12, which labels a negligible
number of T cells from wild-type mice (16; Fig. 1 C). As
shown in Fig. 1, C and D, there was no significant differ-
ence in the repopulation of donor-derived cells that were
of IL-2 KO or IL-2
 
 
 
 origin in T/
 
 
 
 
 
 
 
 
 
 IL-2
 
 
 
 recipients.
As expected given previous reports (13), the frequency of
T cells expressing the IL-2R 
 
 
 
 chain (CD25) was greatly
diminished in IL-2 KO donor mice; however, the expres-
sion of CD25 in donor-derived IL-2 KO T cells slightly
increased after transfer (Fig. 1 E), likely indicating the para-
crine effect of IL-2 produced by the host. Indeed, the pro-
duction of IL-2 by MBP-specific T cells was confirmed by
intracellular staining of CNS-draining deep cervical lymph
node cells of T/
 
 
 
 
 
 
 
 
 
 and TCR Tg RAG
 
 
 
 (T/R
 
 
 
) mice
(Fig. 1 G). A very low frequency (
 
 
 
1%) of circulating
MBP-specific cells expressed CD25 at both time points ir-
respective of the IL-2 genotype of the donor-derived cells;
expectedly, the frequency was higher in the presence of
IL-2
 
 
 
 donor cells (Fig. 1 F).
To confirm the data obtained with splenocytes, we
transferred 3 
 
 
 
 10
 
5
 
 CD4
 
 
 
 single-positive thymocytes from
IL-2 KO and IL-2
 
 
 
 mice. Similarly to what was observed
with splenic T cells, thymic IL-2 KO CD4
 
 
 
 T cells con-
ferred protection from EAE (online supplemental Fig. S1,
A and B), and the expansion of donor-derived IL-2 KO
cells after injection into IL-2
 
 
 
 T/
 
 
 
 
 
 
 
 
 
 mice was not sig-
nificantly different from the expansion undergone by do-
nor-derived IL-2
 
 
 
 cells (online supplemental Fig. S1 C).
The fact that a limiting number of splenic CD4
 
 
 
 T cells
were effective in preventing disease shows that IL-2 is not
necessary for the thymic generation and selection of regula-
tory T cells, and also suggests that IL-2 is not necessary for
the maintenance/survival of these cells in the periphery. If
the latter were the case, we would have expected good
protection from thymic IL-2 KO cells but impaired protec-
tion from splenic IL-2 KO cells. In addition, our results
demonstrate that, at least in this experimental system, regu-
latory T cells do not protect from disease by means of IL-2
secretion (e.g., AICD induction), as CD4
 
 
 
 T cells incapa-
ble of IL-2 production are nevertheless effective in the pre-
vention of spontaneous EAE. Thus, our results show that
CD4
 
 
 
 T cells from IL-2 KO mice, a mouse strain which
develops spontaneous autoimmune disease with 100% inci-
dence, when transferred into T/
 
 
 
 
 
 
 
 
 
 mice, which also de-
velop spontaneous autoimmune disease with 100% inci-
dence, yield mice that appear to be completely healthy.
Splenic Cells from IL-2 KO Mice Prevent Hyper IgE Re-
sponse. Having shown that IL-2 KO CD4  T cells confer
protection against EAE, a spontaneous Th1 cell-mediated
disease directed against a self antigen, we next assessed the
capacity of IL-2 KO T cells to confer protection against
Figure 1. CD4  splenocytes from IL-2 KO mice efficiently protect
against spontaneous EAE. (A–G) 23–27-d-old T/     IL-2  mice were
injected with PBS (n   6) or with 3   105 purified CD4  T cells from
spleens of 3–4-wk-old IL-2 /  (n   10) or IL-2 /  mice (n   7). Mice
were observed for 90 d and EAE was scored as described in Materials and
Methods. (A) Average clinical EAE score. (B) Average EAE incidence.
(C–G) Peripheral blood lymphocytes were collected from all recipient
mice 20 and 40 d after cell transfer, stained with anti-MBP TCR (3H12)
FITC, CD25 PE, CD4 PerCP, and CD3 APC and analyzed by FACS®.
(C) Representative staining indicating the identification of donor-derived
(3H12 ) and recipient-generated (3H12 ) T cells. Gated on CD3  cells.
(D) Expansion of donor-derived (3H12 ) T cells. Cells were stained and
gated as in C. Shown are the mean percentages of clonotype-negative
cells from all mice in each group   SD. (E) Average percentage of CD25
positive T cells (  SD) among the donor-derived CD4  cells
(CD4 3H12  gate). (F) Average percentage of CD25-positive T cells ( 
SD) among the recipient-generated CD4  cells (CD4 3H12  gate). (G)
IL-2 production by MBP-specific T cells. Intracellular IL-2 staining of
deep cervical lymph node cells from a healthy 7-wk-old T/R  and a
7-wk-old T/     mouse with early clinical signs of spontaneous EAE.
Surface staining with anti-CD4 and 3H12. Gated on 3H12  cells.854 Role of Interleukin 2 in Regulatory T Cell Function
hyper IgE. Hyper IgE is a Th2 cell-mediated condition that
can be elicited in mice harboring a monoclonal T and B
cell repertoire as a consequence of immunization with a
foreign antigen (18). In this experimental system, it has
been shown that purified CD4  T cells from wild-type
mice, but not CD8  T cells or B cells, prevent the hyper
IgE response (18).
As shown in Fig. 2 A, singly immunized monoclonal T
and B mice that received no cell transfer developed persis-
tent serum IgE levels of  100  g/ml. In contrast, immu-
nized animals that had been transferred with 1.6   107 total
spleen cells from wild-type or IL-2 KO syngeneic donor
mice displayed IgE responses that were at least 10-fold re-
duced (Fig. 2 A). As was the case with the EAE experiment,
peripheral expansion of donor-derived IL-2 KO and IL-2 
T cells was comparable (Fig. 2 B), and the frequency of
CD25  among circulating CD4  donor-derived IL-2 KO
cells raised to  2% upon transfer in both experimental sys-
tems (Figs. 1 F and 2 C). Also similarly to the EAE system,
the frequency of CD25  cells among circulating OVA-spe-
cific T cells was low ( 2%) 19 and 44 d after immunization
(Fig. 2 D). We have previously shown that CD25 expres-
sion on OVA-specific T cells is quickly up-regulated after
immunization, and is subsequently downregulated irrespec-
tive of the presence of regulatory T cells (18).
We have thus shown that IL-2 KO mice harbor periph-
eral CD4  cells that can prevent spontaneous EAE and
suppress hyper IgE responses.
Splenic and Thymic CD4  Cells from CD25 KO Mice Fail
to Prevent Spontaneous Encephalomyelitis. In the experi-
mental setups described in Figs. 1 and 2, IL-2 is produced
by the host cells and is able to influence the donor-derived
IL-2 KO cells. We subsequently wished to establish
whether IL-2 signaling is required for T-reg function. To
accomplish this goal, we used IL-2R   chain (CD25) KO
mice as a source of putative T-reg cells, as CD25 KO cells
display a greatly impaired response to IL-2. CD25’s only
known function is as an essential component of the high af-
Figure 2. IL-2 KO cells prevent hyper IgE re-
sponse. 17/9 DO11.10 RAG /  BALB/c mice
were transferred with 1.6   107 spleen cells from
3-wk-old IL-2 /  or IL-2 /  BALB/c donor
mice. The recipient mice were immunized by in-
traperitoneal route with OVA-HA in alum 24 h af-
ter the transfer of cells. n   3 recipient mice per
group. Data representative of one of two experi-
ments performed (A). Serum IgE levels 19 and 44 d
after immunization. Data presented as mean IgE
concentration   SD (B–D). Peripheral blood lym-
phocytes were stained with KJ1–26 FITC, CD25
PE, and CD4 PerCP and analyzed by FACS®. Data
presented as mean percentage   SD. (B) Expansion
of CD4  donor-derived cells (CD4 KJ1–26 ) as a
percentage of total lymphocytes (forward scatter  
side scatter lymphocyte gate). (C) Average percent-
age of CD25 positive T cells (  SD) among the
donor-derived CD4  cells (CD4 KJ1–26  gate).
(D) Average percentage of CD25 positive T cells
(  SD) among the recipient’s CD4  cells
(CD4 KJ1–26  gate).
finity IL-2 receptor; thus, the transfer of IL-2R   (CD25)
KO CD4  cells into IL-2R   chain  T/     mice di-
rectly examines the role of IL-2 in the function of regula-
tory T cells. We therefore transferred 3   105 CD4  T
cells from syngeneic IL-2R   chain (CD25) KO mice into
CD25  T/     mice. In stark contrast to IL-2 KO T
cells, neither thymic nor splenic T cells from IL-2R  
chain KO mice conferred a level of disease protection that
was comparable to the one conferred by similar number of
T cells from CD25  littermate donors (Fig. 3, A and B), al-
though thymic CD4  cells from CD25 KO mice did pro-
vide a partial protection. Failure to confer protection was
not due to poor expansion of donor-derived cells in the
T/     recipients, which are genetically competent to ex-
press CD25. To the contrary, thymic and splenic donor-
derived CD25 KO cells expanded to up to 40% of the cir-
culating CD4  pool (Fig. 3 C), the remaining 60% being
host-derived MBP-specific T cells. Failure to confer pro-
tection was also not due to improper homing of the donor-
derived cells (online supplemental Fig. S2).
MBP-specific TCR Transgenic RAG  Mice Spontaneously
Develop EAE. To assess the regulatory potential of IL-2R
  chain KO T cells under constant thymic output of puta-
tive regulatory T cells, we crossed the MBP-specific T cell
receptor transgenic RAG  mice (T/R ), which do not de-
velop EAE spontaneously, with IL-2R   chain KO mice.
As shown in Table I, all T/R  CD25 KO mice developed
EAE spontaneously, whereas none of the T/R  CD25 
littermates did. At the time of severe EAE onset, the recip-
ient animals displayed no signs of wasting disease. As in this
experimental system the protection from EAE depends on
T cells expressing TCR encoded by the endogenous TCR
   loci, we used mice of H-2b/u MHC, which harbor a
proportion of T cells escaping allelic exclusion about three-
fold larger than H-2u/u T/R  mice (Table I and online
supplemental Fig. S3). However, even a larger fraction of
IL-2R    chain KO T cells that expressed endogenous
TCRs was insufficient to confer protection. Thus, regard-855 Furtado et al. Brief Definitive Report
less of whether the MBP-specific T cells were CD25  or
CD25 KO, CD4  T cells of CD25 KO origin failed to
confer adequate protection against spontaneous EAE.
Taken together with all prior observations on IL-2 and
CD25 KO mice, our results support the notion that the
immunostimulatory role of IL-2 on effector T cells can be
exerted by other cytokines, but IL-2 signaling is necessary
for regulatory T cell function.
Discussion
We have shown that CD4  T cells from IL-2 KO mice
were able to protect from spontaneous EAE. In the experi-
mental systems that we used, the T cells from the recipient
mice were capable of producing IL-2; however, IL-2 itself
is not protective, as spontaneous EAE developed in un-
transferred IL-2  T/     mice. T/     mice develop
spontaneous EAE because they cannot generate the TCR
specificity of regulatory T cells (15, 16). Our present data
indicate that IL-2 KO mice select T cells displaying the ap-
propriate T-reg cell repertoire, as T cells with regulatory
potential can be found in the spleen of donor IL-2 KO
mice. The crucial role of IL-2 is evident by the failure of
IL-2R   chain KO T cells to confer protection to CD25 
T/     mice, and by the development of spontaneous
disease in T/R  CD25 KO mice. Although it is formally
possible that CD25 has additional roles that are IL-2 inde-
pendent, this possibility seems highly unlikely given the ex-
tensive research in the field and the overwhelming similari-
ties between IL-2 KO and CD25 KO mice.
In prior work we showed that full protection against
spontaneous EAE could be achieved by CD4 CD25  cells
prepared from wild-type donor mice (20, 21). In this re-
port, we showed that CD4  T cells from IL-2 KO mice,
Table I. EAE Incidence and Lymphocyte Repertoire in H-2b/u
T/R  CD25 KO and CD25 /  Littermates
Mouse
genotype CD4 /V 8.1.2  CD4 /V 8.1.2 
Mice with
EAE/mice
observed
%%
T/R CD25 /  13.3   3.7 1.1   0.6 4/4
T/R CD25 /  16.5   4.2 1.0   0.6 0/10
Peripheral blood was obtained from mice of the indicated genotype at
age 4 wk, and stained with anti-CD4, anti-B220, and anti-V 8.1/8.2
(stains the transgenic chain) antibodies. n   7 for CD25 knockout mice
and n   10 for CD25  mice. Samples of the staining are shown in online
supplemental Fig. S3. Four T/R  CD25 KO mice and all the CD25 
littermates were monitored for EAE development for 4 mo.
Figure 4. Model depicting the possible effect of IL-2 on regulatory T
cells based on the spontaneous EAE data. (reference 1). Self-specific Th
precursor cells encounter self antigen and (reference 2) secrete IL-2. Al-
though costimulatory molecules are not drawn in the model due to lack
of space, in the spontaneous EAE system the generation of MBP-specific
Th effector cells is CD28-dependent (reference 34). (1’) Regulatory T
cells or their precursors interact via TCR with yet unknown ligands, and
(2’) up-regulate the IL-2 receptor. (3’) IL-2 promotes regulatory T cell
differentiation or expansion in the periphery, and/or (4’) triggers regula-
tory functions such as secretion of down-modulatory cytokines. In this
scheme, the source of IL-2 is the self-specific T cell population, although
other activated host cell types could also produce IL-2 (reference 35).
Figure 3. CD25 KO cells do not protect efficiently against spontane-
ous EAE. 23–27 d-old T/     mice were injected with PBS (n   8) or
with 3   105 CD4  T cells from spleen (spl) of CD25 /  mice (n   13),
spleen of CD25 /  mice (n   8), thymus (thy) of CD25 /  mice (n  
3), or thymus of CD25 /  mice (n     3) purified from 3–4-wk-old
CD25 /  and CD25 /  donor mice. Mice were observed for 100 d and
EAE were scored as described in Materials and Methods. (A) Average
clinical EAE score. (B) Average EAE incidence. (C) The expansion of
donor-derived (3H12 ) CD4  T cells in each experimental group was
assessed by peripheral blood staining 25 and 45 d after cell transfer (CD4 
lymphocyte gate). Data presented as mean percentage   SD.856 Role of Interleukin 2 in Regulatory T Cell Function
which, like the sorted CD25  cells, are largely CD25-nega-
tive but genetically CD25 , also protect very effectively
against spontaneous EAE. In contrast, T cells genetically de-
ficient in CD25 protect poorly against spontaneous EAE. It
has been known for many years that IL-2 induces the up-
regulation of the IL-2 receptor (22, 23). Thus, it is very
likely that CD25-negative cells from IL-2 KO mice re-
spond to IL-2 (in these experimental scenarios produced
only by the recipients’ cells) via the intermediate affinity IL-
2R   , and upregulate the expression of CD25 to form the
high affinity IL-2R    . High affinity response to IL-2
then effects the regulatory cells in one of three nonexclusive
ways: (a) induces T-reg precursors to become regulatory in
the periphery, (b) induces T-regs to expand and reach num-
bers that can be effective in the control of autoimmunity or
allergy, and/or (c) triggers their regulatory functions, which
could be mediated via the secretion of down-modulatory
cytokines such as IL-10 and/or TGF-  (Fig. 4).
We have described that CD4  T cells from IL-10 KO
mice are less effective in preventing spontaneous EAE than
CD4  T cells from IL-10  mice (20), although the IL-10
dependence of regulatory T cells is much less noticeable in
the spontaneous EAE model than in IBD models (24, 25).
We have previously shown that, in vivo, T-reg cells pre-
vent the generation of fully differentiated effector Th cells
but do not appreciably block the initial activation and ex-
pansion of Th precursor cells (18). We showed here that the
initial activation of the recipient’s cells may be necessary to
produce IL-2, which is key to the function of regulatory T
cells. One question arises as to how immune responses could
occur if the initial activation of Th precursor cells sets in mo-
tion the T-reg–mediated downregulation of the responses.
Although we do not know the answer to this question, it is
possible that strong stimuli mediated by innate immunity
signals overwhelm the T-reg loop leading to Th-mediated
immune responses, whereas responses to weak stimuli are
thwarted. For instance, MBP-specific T/R  mice, which do
not develop EAE spontaneously due to the presence of
T-reg cells, succumb to a fulminant disease when immunized
with MBP in the presence of complete Freund’s adjuvant
and pertussis toxin (15). We have also shown that regulatory
T cells expand less than conventional T cells when placed
together in TCR transgenic/RAG KO recipient mice (20),
providing one possible explanation for the dominance of Th
immune response over downregulation when stimuli are
strong. In the absence of regulatory T cells, however, even
weak stimuli lead to Th-mediated responses.
A population of CD4 CD25  T cells protects against a
number of experimental autoimmune conditions (25–28).
In vitro studies have shown that CD4 CD25  T cells
block the proliferation and reduce IL-2 mRNA levels of
CD4 CD25  T cells (14, 29). CD4 CD25  T cells prolif-
erate in vitro in the presence of IL-2 and, during the ex-
pansion period, temporarily lose their capacity to block the
proliferation of CD4 CD25  cells. The significance of in
vitro proliferation data to in vivo regulation of autoim-
mune or allergic conditions remains to be clarified. First, in
vitro, CD25  T cells block proliferation only at CD25 /
CD25  ratios that exceed those found in vivo. Second, we
have recently shown that regulatory T cell–mediated pro-
tection against a hyper IgE response in vivo occurred with-
out inhibition of early activation and without blockade of
the initial proliferation of antigen-specific T cells (18).
Third, whereas the control of in vitro proliferation by
CD25  T cells appears to be cytokine independent, in vivo
protection from IBD by CD25  T cells has been shown to
be cytokine dependent (24, 25).
The immunostimulant properties of IL-2 are the basis for
its use in cancer clinical trials. Thus far, however, the re-
sponse rates have been modest in some studies and ex-
tremely low in other studies (30–32). Of interest, in a 14
patient phase II study to evaluate IL-2 treatment in na-
sopharyngeal carcinoma, Chi et al. found that IL-2 was
clinically ineffective, and that, among other parameters, the
treatment led to increased seric levels of IL-10 (33). In light
of the data presented in this manuscript, it is possible that
one of the reasons for the below expectation immunostim-
ulatory responses to IL-2 in vivo could lay on its role in
regulatory T cell function.
In conclusion, IL-2 stimulation may be an important
physiological stimulus for triggering regulatory T cell func-
tion, with potential to enhance the activity of regulatory T
cells in a variety of autoimmune and allergic conditions.
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